Page 130 - Read Online

in hepatocellular carcinoma and contributes to hepatocarcinogenesis by subset of patients with squamous cell carcinoma of the head and neck.
downregulating FOXO3a. PLoS One 2012;7:e40607. Cancer 2011;117:2939-50.
108. Lu M, Ma J, Xue W, Cheng C, Wang Y, Zhao Y, Ke Q, Liu H, Liu Y, Li P, 119. Odvody J, Vincent T, Arrate MP, Grieb B, Wang S, Garriga J, Lozano
Cui X, He S, Shen A. The expression and prognosis of FOXO3a and Skp2 G, Iwakuma T, Haines DS, Eischen CM. A deficiency in Mdm2 binding
in human hepatocellular carcinoma. Pathol Oncol Res 2009;15:679-87. protein inhibits Myc-induced B-cell proliferation and lymphomagenesis.
109. Carbajo-Pescador S, Mauriz JL, Garcia-Palomo A, Gonzalez-Gallego J. Oncogene 2010;29:3287-96.
FoxO proteins: regulation and molecular targets in liver cancer. Curr Med 120. Grieb BC, Chen X, Eischen CM. MTBP is Over-expressed in Triple
Chem 2014;21:1231-46. Negative Breast Cancer and Contributes to its Growth and Survival. Mol
110. Yang JY, Zong CS, Xia W, Yamaguchi H, Ding Q, Xie X, Lang JY, Lai Cancer Res 2014; 12:1216-24.
CC, Chang CJ, Huang WC, Huang H, Kuo HP, Lee DF, Li LY, Lien HC, 121. Grieb BC, Gramling MW, Arrate MP, Chen X, Beauparlant SL, Haines
Cheng X, Chang KJ, Hsiao CD, Tsai FJ, Tsai CH, Sahin AA, Muller WJ,
Mills GB, Yu D, Hortobagyi GN, Hung MC. ERK promotes tumorigenesis DS, Xiao H, Eischen CM. Oncogenic protein MTBP interacts with MYC
by inhibiting FOXO3a via MDM2-mediated degradation. Nat Cell Biol to promote tumorigenesis. Cancer Res 2014;74:3591-602.
2008;10:138-48. 122. Lu S, Zhou W, Wei H, He L, Li L. MTBP Promotes the Invasion and
111. Fu W, Ma Q, Chen L, Li P, Zhang M, Ramamoorthy S, Nawaz Z, Metastasis of Hepatocellular Carcinoma by Enhancing the MDM2-
Shimojima T, Wang H, Yang Y, Shen Z, Zhang Y, Zhang X, Nicosia SV, Mediated Degradation of E-Cadherin. Dig Dis Sci 2015;60:3681-90.
Zhang Y, Pledger JW, Chen J, Bai W. MDM2 acts downstream of p53 123. Aleixo PB, Hartmann AA, Menezes IC, Meurer RT, Oliveira AM.
as an E3 ligase to promote FOXO ubiquitination and degradation. J Biol Can MDM2 and CDK4 make the diagnosis of well differentiated/
Chem 2009;284:13987-4000. dedifferentiated liposarcoma? An immunohistochemical study on 129 soft
112. Brenkman AB, de Keizer PL, van den Broek NJ, Jochemsen AG, tissue tumours. J Clin Pathol 2009;62:1127-35.
Burgering BM. Mdm2 induces mono-ubiquitination of FOXO4. PLoS 124. Reifenberger G, Liu L, Ichimura K, Schmidt EE, Collins VP. Amplification
One 2008;3:e2819. and overexpression of the MDM2 gene in a subset of human malignant
113. Boyd MT, Vlatkovic N, Haines DS. A novel cellular protein (MTBP) gliomas without p53 mutations. Cancer Res 1993;53:2736-9.
binds to MDM2 and induces a G1 arrest that is suppressed by MDM2. J 125. Bond GL, Hu W, Bond EE, Robins H, Lutzker SG, Arva NC, Bargonetti
Biol Chem 2000;275:31883-90. J, Bartel F, Taubert H, Wuerl P, Onel K, Yip L, Hwang SJ, Strong LC,
114. Agarwal N, Tochigi Y, Adhikari AS, Cui S, Cui Y, Iwakuma T. MTBP Lozano G, Levine AJ. A single nucleotide polymorphism in the MDM2
plays a crucial role in mitotic progression and chromosome segregation. promoter attenuates the p53 tumor suppressor pathway and accelerates
Cell Death Differ 2011;18:1208-19. tumor formation in humans. Cell 2004;119:591-602.
115. Agarwal N, Adhikari AS, Iyer SV, Hekmatdoost K, Welch DR, Iwakuma 126. Weber JD, Taylor LJ, Roussel MF, Sherr CJ, Bar-Sagi D. Nucleolar Arf
T. MTBP suppresses cell migration and filopodia formation by inhibiting sequesters Mdm2 and activates p53. Nat Cell Biol 1999;1:20-6.
ACTN4. Oncogene 2013;32:462-70.
116. Bi Q, Ranjan A, Fan R, Agarwal N, Welch DR, Weinman SA, Ding J, 127. Malmlof M, Roudier E, Hogberg J, Stenius U. MEK-ERK-mediated
Iwakuma T. MTBP inhibits migration and metastasis of hepatocellular phosphorylation of Mdm2 at Ser-166 in hepatocytes. Mdm2 is activated
carcinoma. Clin Exp Metastasis 2015;32:301-11. in response to inhibited Akt signaling. J Biol Chem 2007;282:2288-96.
117. Iwakuma T, Tochigi Y, Van Pelt CS, Caldwell LC, Terzian T, Parant JM, 128. Capoulade C, Bressac-de Paillerets B, Lefrere I, Ronsin M, Feunteun J,
Chau GP, Koch JG, Eischen CM, Lozano G. Mtbp haploinsufficiency in Tursz T, Wiels J. Overexpression of MDM2, due to enhanced translation,
mice increases tumor metastasis. Oncogene 2008;27:1813-20. results in inactivation of wild-type p53 in Burkitt’s lymphoma cells.
118. Vlatkovic N, El-Fert A, Devling T, Ray-Sinha A, Gore DM, Rubbi CP, Oncogene 1998;16:1603-10.
Dodson A, Jones AS, Helliwell TR, Jones TM, Boyd MT. Loss of MTBP 129. Zhao Y, Yu H, Hu W. The regulation of MDM2 oncogene and its impact on
expression is associated with reduced survival in a biomarker-defined human cancers. Acta Biochim Biophys Sin (Shanghai) 2014;46:180-9.

121 Hepatoma Research | Volume 2 | May 6, 2016